Advertisement

Hematoporphyrin Derivative Phototherapy in Experimental Oncology

  • Gianfranco Canti
  • Laura Ricci
  • Paola Franco
  • Angelo Nicolin
  • Alessandra Andreoni
  • Rinaldo Cubeddu

Abstract

Photoradiation therapy is currently under investigation as a new form of treatment for solid malignant tumors in human. The method involves photosensitization of drugs and fluorescent dyes, such as Hematoporphyrin1. This dye has been shown to accumulate with a certain degree of specificity in tissues with a high mitotic index2. Moreover, neoplastic tissue might be identified by the fluorescence emitted from cancerous lesions that have incorporated the dye in larger amounts than normal tissues3. The photodynamic action has implicated singlet oxygen Ca short-lived excited molecular state of ground-state triplet oxygen) as the effective cytotoxic agent4.

Keywords

L1210 Cell Photodynamic Action High Mitotic Index2 Immune Lymphocyte Syngeneic Animal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    T.J. Dougherty, Activated dyes as antitumor agents, J.Natl. Cancer Inst. 52:1333 [1974]Google Scholar
  2. 2.
    F.H.H. Figge, G.S. Weiland, L.O. Nanganiello, Cancer detection and therapy affinity of neoplastic embryonic and traumatized tissues for porphyrin and metalloporphyrin. Proc.Soc.Exp.Biol. Ned. 68:640 [1948]Google Scholar
  3. 3.
    H.B. Gregorio, E.O. Horger, J.L. Ward, J.F. Green, T. Richards, H.C. Robertson, T.B. Stevenson., Hematoporphyrin derivative fluorescence in malignant neoplasma. Ann.Surg. 167:820 (1968)CrossRefGoogle Scholar
  4. 4.
    K.R. Weishaupt, C.J. Gomer, T.J. Dougherty, Identification of singlet oxygen as the cytotoxic agent photoinactivation of murine tumors. Cancer Res.36:2326 (1976)Google Scholar
  5. 5.
    T.J. Dougherty, G.B. Grindey, R. Fiel, R.R. Weishaupt, D.G. Boyle. Photoradiation therapy: Cure of animals tumors with hematoporphyrin and light. J.Natl.Cancer Inst. 55:115 (1975)Google Scholar
  6. 6.
    T.J. Dougherty, J.E. Kaufman, A. Goldfarb, K.A. Weishaupt, D. Boyle, A. Mittelman. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 38:2628 (1978)Google Scholar
  7. 7.
    T.J. Dougherty, G. Lawrence, J.E. Kaufman, D.G. Boyle, K.R. Weishaupt, A. Goldfarb. Photoradiation in the treatment of recurrent breast carcinoma. J.Natl.Cancer Inst. 62:231 (1979)Google Scholar
  8. 8.
    A. Dahlman, A.G. Wile, R.G. Burns, G.R. Hason, F.H. Johnson, M.W. Berns. Laser photoradiation therapy of cancer. Cancer Res. 43:430 (1983)Google Scholar
  9. 9.
    Y. Hayata, K. Harubruni, C. Kanaka, J. Ono, M. Takizawa. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 81:269 (1982)CrossRefGoogle Scholar
  10. 10.
    G. Canti, O. Marelli, L. Ricci, A. Nicolin. Hematoporphyrin-treated murine lymphocytes:in vitro inhibition of DNA synthesis and light mediated inactivation of cells responsible for GVHR. Photoch. and Photobiol. 34:589 (1981)Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Gianfranco Canti
    • 1
  • Laura Ricci
    • 1
  • Paola Franco
    • 1
  • Angelo Nicolin
    • 1
    • 2
  • Alessandra Andreoni
    • 1
    • 3
  • Rinaldo Cubeddu
    • 1
    • 3
  1. 1.Dept. of PharmacologySchool of MedicineMilanItaly
  2. 2.I.S.T.GenoaItaly
  3. 3.Center for Quantum ElectronicsMilanItaly

Personalised recommendations